DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced the launch of DeviceVue, a comprehensive asset ...

DEERFIELD, Ill., & SALT LAKE CITY--(BUSINESS WIRE)-- Intermountain Healthcare and Baxter Healthcare Corporation today announced the successful integration of the SIGMA Spectrum Infusion System into ...

The Spectrum infusion pumps are used to deliver medications, nutrients and other fluids directly to a patient’s body via IV, so any interruptions to that delivery could be potentially life-threatening ...

Baxter recalled over 277,000 infusion pumps due to the risk of the device failing to alarm users of repeated upstream occlusion events. The SIGMA Spectrum Infusion Pump with Master Drug Library ...

On April 20, 2022, Rapid7 discovered vulnerabilities in two TCP/IP–enabled medical devices produced by Baxter Healthcare. The flaws, four in total, affected the company’s SIGMA Spectrum Infusion Pump ...

Baxter Healthcare has issued a recall for some Spectrum infusion pumps due to a potential defect involving missing motor mounting screws, which could lead to interruptions, delays or incorrect dosing ...

Baxter International Inc.BAX recently announced the launch of comprehensive asset tracking solution DeviceVue. The solution will be used alongside the company's proprietary pump system, Sigma Spectrum ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced the U.S. Food and Drug Administration (FDA) ...

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas ...

Baxter International has announced it has completed its acquisition of SIGMA International General Medical Apparatus, according to a news release. In 2009, Baxter acquired 40 percent of the privately ...

The now-recalled versions of both drug-dosing software programs were themselves originally meant to be a fix for Baxter’s last Class I infusion pump recall. In that case, certain versions of Master ...